How to Successfully Transition Your Career: Industry and Academia

Thank you

This live web event has ended. Thank you for attending.

Description

In this session, we will discuss the challenges, opportunities and practical approaches required for the successful transition from academics to industry and vice versa. Successful scientists drive pharmaceutical science forward and most of the time their job selection depends on research interest, academic freedom, visa and financial benefit. Maintaining a successful career in academic settings during reduced government grant support is critical. Similarly, maintaining a successful career in the industry driven by the stock market during a recession is critical. While basic research is the focus at universities, applied research is the focus of the pharmaceutical industry. Successful collaboration and transition of manpower between academy and industry are critical for drug discovery and development. There are examples of successful transitions from academics to industry and vice versa, but many people struggle during the transition. Here we would decode the successful transition from both institutions so that many pharmaceutical professionals would be benefitted from such transitions. Additionally, transitions within an institution will be discussed to advise scientists looking to shift their focus, transfer between departments or broaden their scope to a more overseeing role. Various critical factors, including goal setting, networking, mentorship, professional development, grant writing, and teamwork are discussed which are essential for career transition.

The following important points will be discussed:

Identifying suitable job opportunities in the academic institutions and pharmaceutical industry.
How to successfully transition from academy to industry and vice versa?
How to successfully transition within an institution?
How to write an impressive grant?
How to set a goal and achieve it?
How to build and maintain a useful network?
How to find mentors and connect with them?
How to grow professionally?
How to maximize teamwork and benefit?

Contributors

Kimberley Lentz, Ph.D.

Kimberley Lentz received her PhD from the University of Maryland and now brings 20+ years of experience in the pharmaceutical industry. She began her career as a DMPK scientist supporting preclinical programs in Virology and Neuroscience before progressing to DMPK leadership positions to the evolving the thrombosis, metabolics, and heart failure pipeline. Utilizing this broad expertise, she transitioned to Early Development as a Program Leader to several Ph1/2 programs inclusive of Cardiovascular, Fibrosis and Oncology. Her track record in effectively working across various therapeutic areas, coupled with experience in drug discovery and development strategy, positioned her well for her current role as Head of Portfolio Strategy and Integration for Research at Bristol Myers Squibb. Kim values a high performing, collaborative, and truth-seeking team environment aimed at developing integrated strategies to achieve portfolio objectives.
Dhaval K. Shah, Ph.D.

Dr. Shah received a doctorate in pharmaceutical sciences from the University at Buffalo, The State University of New York, and joined UB as an Assistant Professor in 2013. Previously, he held a position of Principal Scientist at Pfizer. Dr. Shah’s research focuses on understanding the determinants for the ADME of protein therapeutics. He is involved in the development of a platform PBPK model for biologics that can characterize and predict the pharmacokinetics of diverse protein therapeutics in several preclinical species and human. Dr. Shah also directs the discovery, development and clinical translation of novel protein therapeutics like antibody-drug conjugates and bi-specific molecules in his laboratory.

Thank you

Description

Contributors

Kimberley Lentz, Ph.D.

Dhaval K. Shah, Ph.D.